World of DTC Marketing

SEPTEMBER 7, 2022

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. The biggest battle arena by far is oncology. oncology therapeutics market has reached $71 billion. oncology therapeutics market has reached $71 billion. ” The U.S.

Pharma 210

Pharma Food and Drug Administration Marketing Prescription 210

Pharmaceutical Technology

FEBRUARY 10, 2023

On November 22, 2022, the FDA approved CSL Behring’s Hemgenix (etranacogene dezaparvovec), the first gene therapy treatment for hemophilia B, with a staggering manufacturer price of $3.5 million, according to GlobalData’s Price Intelligence (POLI), making it the most expensive drug in the world.

Marketing 105

Marketing Medicine Leads Safety 105

Pharmaceutical Technology

MAY 2, 2023

Immuno-oncology (IO) agents have transformed the cancer therapeutics landscape, driving long-term remissions in a subset of patients who historically had limited options. IO therapies come with a hefty price tag, with ICI therapies in the US typically exceeding $100,000, while cell therapies can exceed $400,000.

Physicians 52

Physicians Marketing Patients Manufacturing 52

PM360

APRIL 7, 2023

In fact, the introduction of CGTs heightens the need for pro-active planning and a longer runway to support optimal health plan coverage and pricing for expensive therapies as well as to prepare HCPs for prescribing decisions. This data will influence the adoption of value-based pricing and attract broad reimbursement.

Manufacturing 52

Manufacturing Marketing Patients Safety 52

European Pharmaceutical Review

DECEMBER 27, 2023

This is in addition to its considerable price tag. About the author Professor Arnon Nagler, MD is President of the Hemato-Oncology Center and director of the Division of Hematology and the Bone Marrow Transplantation and Cord Blood Bank at the Sheba Medical Center, and Professor of Medicine at Tel Aviv University in Israel.

Manufacturing 87

Manufacturing Food and Drug Administration Patients Pharma 87

Pharmaceutical Technology

MARCH 17, 2023

On 16 March, Watt spoke at GlobalData webinar titled “Pharma [POLI]: Market Access Risk Outlook”, providing a current outlook on the pharmaceutical pricing and reimbursement environments around the world, including key reforms, risks and opportunities. This may be because access to oncology drugs varies widely across the world, she added.

Marketing 102

Marketing Pharma Pharmaceutical Healthcare 102